drugset / Trial / NCT03407378

A Study to Investigate a New Treatment in Patients With Parkinson's Disease

NCT03407378 ↗

Phase 1/2 Completed 110 enrolled Tools4Patient
RandomizedParallel-groupSingle-blindBasic science

Summary

The purpose of this clinical trial conducted in patients with Parkinson's Disease is to study the relationship between patient individual profile and their response to IPT803 Adjunct Treatment (treatment response being characterized by movements improvement).

Timeline

Start
2018-06-26
Primary completion
2020-02-07
Completion
2020-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject IPT803 Unknown — —

Indications